Barinthus Biotherapeutics plc
BRNS
$0.74
-$0.02-2.49%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 59.30M | 65.86M | 70.46M | 74.27M | 86.26M |
| Total Receivables | 1.63M | 1.40M | 1.31M | 4.89M | 5.01M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.87M | 3.88M | 4.52M | 5.41M | 6.35M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 486.00K | 1.53M | 1.51M | 2.20M | 2.79M |
| Total Current Assets | 63.27M | 72.66M | 77.79M | 86.78M | 100.41M |
|
|
|||||
| Total Current Assets | 63.27M | 72.66M | 77.79M | 86.78M | 100.41M |
| Net Property, Plant & Equipment | 4.66M | 4.90M | 5.16M | 6.58M | 7.84M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 13.05M | 13.67M | 14.29M | 14.91M | 20.37M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 919.00K | 914.00K | 930.00K | 929.00K | 944.00K |
| Total Assets | 81.89M | 92.14M | 98.17M | 109.20M | 129.56M |
|
|
|||||
| Total Accounts Payable | 535.00K | 993.00K | 350.00K | 698.00K | 1.80M |
| Total Accrued Expenses | 8.83M | 7.67M | 6.25M | 6.68M | 7.36M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.72M | 2.01M | 2.02M | 2.02M | 2.04M |
| Total Finance Division Other Current Liabilities | 335.00K | 1.33M | 1.40M | 1.40M | 1.53M |
| Total Other Current Liabilities | 335.00K | 1.33M | 1.40M | 1.40M | 1.53M |
| Total Current Liabilities | 11.42M | 12.00M | 10.02M | 10.80M | 12.73M |
|
|
|||||
| Total Current Liabilities | 11.42M | 12.00M | 10.02M | 10.80M | 12.73M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.57M | 9.00M | 9.26M | 9.55M | 9.95M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.77M | 4.66M | 4.60M | 4.29M | 4.40M |
| Total Liabilities | 24.76M | 25.67M | 23.88M | 24.64M | 27.08M |
|
|
|||||
| Common Stock & APIC | 394.93M | 394.50M | 393.95M | 393.25M | 393.66M |
| Retained Earnings | -320.21M | -309.63M | -304.09M | -293.00M | -278.44M |
| Treasury Stock & Other | -17.65M | -18.47M | -15.65M | -15.78M | -12.85M |
| Total Common Equity | 57.07M | 66.40M | 74.21M | 84.47M | 102.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 57.07M | 66.40M | 74.21M | 84.47M | 102.38M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 61.00K | 79.00K | 84.00K | 96.00K | 104.00K |
| Total Equity | 57.13M | 66.48M | 74.29M | 84.56M | 102.48M |
|
|
|||||